Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CEP NASDAQ:HHGC NASDAQ:INV NASDAQ:KVAC On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCEPCantor Equity Partners$33.65-4.5%$35.71$9.99▼$59.75$451.07MN/A1.17 million shs1.04 million shsHHGCHHG Capital$11.12$11.24$10.77▼$13.45$56.16M-0.09N/AN/AINVInnventure$4.98+0.2%$5.16$3.00▼$18.75$265.83M0.18137,617 shs112,953 shsKVACKeen Vision Acquisition$11.50+0.8%$11.34$10.62▼$11.52$220.58M-0.0454,570 shs30,850 shs7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCEPCantor Equity Partners+4.94%+12.05%-1.26%+230.89%+3,523,999,900.00%HHGCHHG Capital0.00%0.00%0.00%0.00%-3.47%INVInnventure+0.20%+0.20%+0.20%+56.78%+496,999,900.00%KVACKeen Vision Acquisition-0.26%-0.27%+0.93%+1.20%+7.25%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCEPCantor Equity PartnersN/AN/AN/AN/AN/AN/AN/AN/AHHGCHHG CapitalN/AN/AN/AN/AN/AN/AN/AN/AINVInnventure2.7836 of 5 stars3.80.00.00.02.22.50.6KVACKeen Vision AcquisitionN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCEPCantor Equity Partners 0.00N/AN/AN/AHHGCHHG Capital 0.00N/AN/AN/AINVInnventure 3.50Strong Buy$14.00181.12% UpsideKVACKeen Vision Acquisition 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCEPCantor Equity PartnersN/AN/A$0.11 per share293.29($0.12) per shareN/AHHGCHHG CapitalN/AN/A$0.27 per share40.90($0.38) per shareN/AINVInnventure$1.22M218.34N/AN/A$17.18 per share0.29KVACKeen Vision AcquisitionN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCEPCantor Equity Partners$1.54MN/A0.00∞N/AN/AN/AN/AN/AHHGCHHG Capital$1.37M$0.06185.36∞N/AN/A-77.66%4.10%N/AINVInnventure-$78.19MN/A0.00N/AN/AN/A-21.70%-15.11%8/18/2025 (Estimated)KVACKeen Vision AcquisitionN/AN/A0.00∞N/AN/AN/AN/A7/23/2025 (Estimated)Latest HHGC, KVAC, CEP, and INV EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/15/2025Q1 2025INVInnventure-$0.13$0.60+$0.73-$3.10$0.58 million$0.22 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCEPCantor Equity PartnersN/AN/AN/AN/AN/AHHGCHHG CapitalN/AN/AN/AN/AN/AINVInnventureN/AN/AN/AN/AN/AKVACKeen Vision AcquisitionN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCEPCantor Equity PartnersN/A0.350.35HHGCHHG CapitalN/A0.190.19INVInnventure0.020.220.11KVACKeen Vision AcquisitionN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCEPCantor Equity PartnersN/AHHGCHHG Capital4.00%INVInnventure55.98%KVACKeen Vision Acquisition51.72%Insider OwnershipCompanyInsider OwnershipCEPCantor Equity Partners4.90%HHGCHHG Capital5.02%INVInnventure23.13%KVACKeen Vision Acquisition40.81%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCEPCantor Equity PartnersN/A12.80 million12.17 millionN/AHHGCHHG Capital25.05 million4.80 millionNot OptionableINVInnventureN/A53.49 million41.12 millionN/AKVACKeen Vision AcquisitionN/A19.37 million11.46 millionNot OptionableHHGC, KVAC, CEP, and INV HeadlinesRecent News About These CompaniesKeen Vision Acquisition (NASDAQ:KVAC) Stock Price Down 0.1% - Here's WhyJuly 17 at 5:44 AM | marketbeat.comKVAC Keen Vision Acquisition Corporation - Seeking AlphaJune 29, 2025 | seekingalpha.comKeen Vision Issues Promissory Note to Extend DeadlineJune 27, 2025 | tipranks.comKeen Vision Acquisition Corporation (KVACW) - Yahoo FinanceJune 27, 2025 | au.finance.yahoo.comKeen Vision Acquisition (NASDAQ:KVAC) Stock Price Up 0.5% - Here's What HappenedJune 25, 2025 | marketbeat.comMedera and Novoheart Presented Breakthroughs in Human mini-Heart Platforms and Gene Therapy at ISSCR 2025June 13, 2025 | globenewswire.comKeen Vision Acquisition Corporation Ordinary SharesJune 6, 2025 | fxempire.comFMedera to Present Late-Breaking Phase 1/2a Clinical Trial Results at Heart Failure 2025 CongressMay 12, 2025 | globenewswire.comMedera Presented Updated Results from First-In-Human Gene Therapy Trial for Heart Failure with Preserved Ejection Fraction at 2025 HFpEF SummitApril 1, 2025 | globenewswire.comKeen Vision Acquisition Corp. Secures Funding to Extend Merger DeadlineMarch 30, 2025 | investing.comMedera Receives DSMB Clearance to Initiate Phase 2 Portion of MUSIC-HFrEF Phase 1b/2 Trial for SRD-001 Gene Therapy in Heart Failure with Reduced Ejection FractionMarch 20, 2025 | globenewswire.comMedera Completes Patient Dosing for Heart Failure TreatmentMarch 11, 2025 | finance.yahoo.comMedera Completes Patient Dosing in Phase 1/2a MUSIC-HFrEF Trial of SRD-001 Gene Therapy for Heart Failure with Reduced Ejection FractionMarch 11, 2025 | globenewswire.comKeen Vision Acquisition Corp. extends business combination periodMarch 1, 2025 | uk.investing.comMedera's Novoheart Expands Human Cardiac Research with CTScreen™ Installation at University Medical Center, UtrechtFebruary 10, 2025 | globenewswire.comMedera, Inc. to Participate in Two Upcoming Investor ConferencesFebruary 7, 2025 | globenewswire.comKeen Vision Acquisition Corp. extends Business combination deadlineJanuary 24, 2025 | msn.comKVAC stock soars to all-time high of $11.03 amid market optimismJanuary 22, 2025 | msn.com(KVAC) Long Term Investment AnalysisJanuary 22, 2025 | news.stocktradersdaily.comNWhen the Price of (KVAC) Talks, People ListenNovember 29, 2024 | news.stocktradersdaily.comNKeen Vision Acquisition Corp Share Price (KVAC.US)November 6, 2024 | lse.co.ukNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesValue vs Growth Ratio Hits Cycle Low—Top Value Picks to BuyBy Gabriel Osorio-Mazilli | June 30, 2025View Value vs Growth Ratio Hits Cycle Low—Top Value Picks to BuyQualcomm’s Hold Rating Misses Strong Growth StoryBy Jeffrey Neal Johnson | July 4, 2025View Qualcomm’s Hold Rating Misses Strong Growth Story3 Retail Stocks to Watch as Back-to-School Spending Ramps UpBy Chris Markoch | July 14, 2025View 3 Retail Stocks to Watch as Back-to-School Spending Ramps UpCoinbase: Analysts Call for New Ceilings—What's Driving Gains?By Gabriel Osorio-Mazilli | June 27, 2025View Coinbase: Analysts Call for New Ceilings—What's Driving Gains?Analysts Upgrade Roku Stock: Can It Deliver and Go Beyond?By Gabriel Osorio-Mazilli | July 15, 2025View Analysts Upgrade Roku Stock: Can It Deliver and Go Beyond?HHGC, KVAC, CEP, and INV Company DescriptionsCantor Equity Partners NASDAQ:CEP$33.65 -1.59 (-4.51%) Closing price 04:00 PM EasternExtended Trading$34.00 +0.35 (+1.04%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Cantor Equity Partners, Inc. is a blank check company, which engages in the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded on November 11, 2020 and is headquartered in New York, NY.HHG Capital NASDAQ:HHGCHHG Capital Corporation does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other business combination with one or more businesses. The company was incorporated in 2020 and is based in Singapore.Innventure NASDAQ:INV$4.98 +0.01 (+0.20%) As of 04:00 PM EasternInnventure Inc. founds, funds and operates companies with a focus on transformative, sustainable technology solutions acquired or licensed from multinational corporations. Innventure Inc., formerly known as Learn CW Investment Corporation, is based in ORLANDO, Fla.Keen Vision Acquisition NASDAQ:KVAC$11.52 +0.12 (+1.04%) As of 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Keen Vision Acquisition Corporation does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, and related business combination with one or more businesses or entities. It also intends to focus on businesses in the biotechnology, consumer goods, and agriculture sectors. The company was incorporated in 2021 and is based in Summit, New Jersey. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas High-Flying GE Aerospace Drops After Blowout Q2 — What Now? A New $70 Billion AI Investment Could Push Taiwan Semiconductor Why Prologis May Be the Smartest Backdoor Bet on AI Real Estate Is Amazon Really the Best Forever Stock for Your Portfolio? Qualcomm: Undervalued Chip Stock in Breakout Uptrend Broadcom’s Takes on NVIDIA: Why Tomahawk Ultra Could Boost Shares CrowdStrike Bulls Beware: This Trade May Be Getting Crowded AMD Just Triggered a Signal Traders Can’t Ignore Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
